Ohio Public Employees Retirement System (OPERS)
VERV

Ohio Public Employees Retirement System (OPERS)’s Verve Therapeutics VERV Stock Holding History

Ohio Public Employees Retirement System (OPERS)’s Portfolio VERV Stock Details VERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-21,440
Closed -$98K – 2375
2025
Q1 		$98K Sell
21,440
-84,916
-80% -$569K ﹤0.01% 1773
2024
Q4 		$600K Buy
106,356
+47,656
+81% +$269K ﹤0.01% 1470
2024
Q3 		$284K Buy
58,700
+12,600
+27% +$73.2K ﹤0.01% 1499
2024
Q2 		$225K Buy
+46,100
New +$290K ﹤0.01% 1357

Other funds holding VERV

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ohio Public Employees Retirement System (OPERS)'s VERV Position: Q2 2025 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Verve Therapeutics (VERV) in Q2 2025, closing a stake of 21,440 shares — an estimated $98K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in VERV in Q2 2024 and held it in 4 quarters. The position peaked at $600K in Q4 2024. 175 funds tracked by Wall St. Rank hold VERV as of Q2 2025.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining Verve Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 21,440 Verve Therapeutics shares in Q2 2025, an estimated $98K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Verve Therapeutics in Q2 2024 and held it in 4 quarters.
  • Ohio Public Employees Retirement System (OPERS)'s Verve Therapeutics position peaked at $600K in Q4 2024.
  • 175 funds tracked by Wall St. Rank held Verve Therapeutics as of Q2 2025.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q2 2025, filed 15 Jul 2025.